These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 32141703)

  • 1. Absence of Bsep/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in mice.
    Fuchs CD; Krivanec S; Steinacher D; Mlitz V; Wahlström A; Stahlman M; Claudel T; Scharnagl H; Stojakovic T; Marschall HU; Trauner M
    Liver Int; 2020 Jun; 40(6):1366-1377. PubMed ID: 32141703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis.
    Wu W; Liu X; Peng X; Xue R; Ji L; Shen X; Chen S; Gu J; Zhang S
    Biochem Biophys Res Commun; 2014 May; 448(1):50-5. PubMed ID: 24747563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous knockout of Bile salt export pump ameliorates liver steatosis in mice fed a high-fat diet.
    Okushin K; Tsutsumi T; Ikeuchi K; Kado A; Enooku K; Fujinaga H; Yamauchi N; Ushiku T; Moriya K; Yotsuyanagi H; Koike K
    PLoS One; 2020; 15(8):e0234750. PubMed ID: 32785220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic preconditioning protects BSEP/ABCB11
    Fuchs CD; Paumgartner G; Wahlström A; Schwabl P; Reiberger T; Leditznig N; Stojakovic T; Rohr-Udilova N; Chiba P; Marschall HU; Trauner M
    J Hepatol; 2017 Jan; 66(1):95-101. PubMed ID: 27593105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of bile salt export pump aggravates lipopolysaccharide-induced liver injury in mice due to impaired hepatic endotoxin clearance.
    Remetic J; Ghallab A; Hobloss Z; Brackhagen L; Hassan R; Myllys M; Radun R; Mlitz V; Zhu C; Baumgartner M; Schrottmaier WC; Mussbacher M; Timelthaler G; Scharnagl H; Stojakovic T; Assinger A; Fuchs CD; Hengstler JG; Trauner M
    Hepatology; 2022 May; 75(5):1095-1109. PubMed ID: 34927748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury.
    Qiu X; Zhang Y; Liu T; Shen H; Xiao Y; Bourner MJ; Pratt JR; Thompson DC; Marathe P; Humphreys WG; Lai Y
    Mol Pharm; 2016 Apr; 13(4):1206-16. PubMed ID: 26910619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dan-shen Yin promotes bile acid metabolism and excretion to prevent atherosclerosis via activating FXR/BSEP signaling pathway.
    Sheng Y; Meng G; Zhang M; Chen X; Chai X; Yu H; Han L; Wang Q; Wang Y; Jiang M
    J Ethnopharmacol; 2024 Aug; 330():118209. PubMed ID: 38663779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.
    Zhang Y; Lickteig AJ; Csanaky IL; Klaassen CD
    Toxicol Sci; 2017 Dec; 160(2):351-360. PubMed ID: 28973556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia.
    Jha P; Claudel T; Baghdasaryan A; Mueller M; Halilbasic E; Das SK; Lass A; Zimmermann R; Zechner R; Hoefler G; Trauner M
    Hepatology; 2014 Mar; 59(3):858-69. PubMed ID: 24002947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation.
    Sheng L; Jena PK; Hu Y; Liu HX; Nagar N; Kalanetra KM; French SW; French SW; Mills DA; Wan YY
    J Pathol; 2017 Dec; 243(4):431-441. PubMed ID: 28892150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis.
    Csak T; Bala S; Lippai D; Kodys K; Catalano D; Iracheta-Vellve A; Szabo G
    PLoS One; 2015; 10(6):e0129251. PubMed ID: 26042593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disordered farnesoid X receptor signaling is associated with liver carcinogenesis in Abcb11-deficient mice.
    Wang L; Luo Q; Zeng S; Lou Y; Li X; Hu M; Lu L; Liu Z
    J Pathol; 2021 Dec; 255(4):412-424. PubMed ID: 34410012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soyasaponin A
    Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L
    Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by
    Ye X; Huang D; Dong Z; Wang X; Ning M; Xia J; Shen S; Wu S; Shi Y; Wang J; Wan X
    Microbiol Spectr; 2022 Oct; 10(5):e0051822. PubMed ID: 36036629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice.
    Gyamfi MA; Tanaka Y; He L; Klaassen CD; Wan YJ
    Toxicol Appl Pharmacol; 2009 Jan; 234(2):166-78. PubMed ID: 18952117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low retinol levels differentially modulate bile salt-induced expression of human and mouse hepatic bile salt transporters.
    Hoeke MO; Plass JR; Heegsma J; Geuken M; van Rijsbergen D; Baller JF; Kuipers F; Moshage H; Jansen PL; Faber KN
    Hepatology; 2009 Jan; 49(1):151-9. PubMed ID: 19111018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic overexpression of murine Abcb11 increases hepatobiliary lipid secretion and reduces hepatic steatosis.
    Figge A; Lammert F; Paigen B; Henkel A; Matern S; Korstanje R; Shneider BL; Chen F; Stoltenberg E; Spatz K; Hoda F; Cohen DE; Green RM
    J Biol Chem; 2004 Jan; 279(4):2790-9. PubMed ID: 14570929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice.
    Ip E; Farrell GC; Robertson G; Hall P; Kirsch R; Leclercq I
    Hepatology; 2003 Jul; 38(1):123-32. PubMed ID: 12829994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
    Zhang J; Zhang H; Deng X; Zhang N; Liu B; Xin S; Li G; Xu K
    Life Sci; 2018 Jan; 192():46-54. PubMed ID: 29158052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.